全文获取类型
收费全文 | 20536篇 |
免费 | 1406篇 |
国内免费 | 120篇 |
专业分类
耳鼻咽喉 | 283篇 |
儿科学 | 480篇 |
妇产科学 | 371篇 |
基础医学 | 2732篇 |
口腔科学 | 475篇 |
临床医学 | 1938篇 |
内科学 | 3780篇 |
皮肤病学 | 216篇 |
神经病学 | 2434篇 |
特种医学 | 719篇 |
外国民族医学 | 1篇 |
外科学 | 2604篇 |
综合类 | 247篇 |
一般理论 | 14篇 |
预防医学 | 1989篇 |
眼科学 | 714篇 |
药学 | 1747篇 |
中国医学 | 47篇 |
肿瘤学 | 1271篇 |
出版年
2023年 | 81篇 |
2022年 | 150篇 |
2021年 | 341篇 |
2020年 | 198篇 |
2019年 | 307篇 |
2018年 | 406篇 |
2017年 | 324篇 |
2016年 | 314篇 |
2015年 | 370篇 |
2014年 | 576篇 |
2013年 | 893篇 |
2012年 | 1298篇 |
2011年 | 1372篇 |
2010年 | 732篇 |
2009年 | 619篇 |
2008年 | 1271篇 |
2007年 | 1386篇 |
2006年 | 1358篇 |
2005年 | 1405篇 |
2004年 | 1364篇 |
2003年 | 1266篇 |
2002年 | 1256篇 |
2001年 | 234篇 |
2000年 | 210篇 |
1999年 | 259篇 |
1998年 | 273篇 |
1997年 | 260篇 |
1996年 | 207篇 |
1995年 | 236篇 |
1994年 | 150篇 |
1993年 | 187篇 |
1992年 | 164篇 |
1991年 | 143篇 |
1990年 | 145篇 |
1989年 | 141篇 |
1988年 | 117篇 |
1987年 | 137篇 |
1986年 | 126篇 |
1985年 | 144篇 |
1984年 | 142篇 |
1983年 | 133篇 |
1982年 | 174篇 |
1981年 | 192篇 |
1980年 | 162篇 |
1979年 | 103篇 |
1978年 | 102篇 |
1977年 | 121篇 |
1976年 | 101篇 |
1975年 | 64篇 |
1974年 | 44篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
72.
Ian R. Falconer Michael D. Burch Dennis A. Steffensen Mandy Choice O. Robert Coverdale 《Environmental toxicology》1994,9(2):131-139
Hepatotoxins from blue-green algae are increasingly recognized as a potential hazard in drinking water supplies. The clinical consequences of ingestion include acute or chronic liver injury, with the possibility of enhanced susceptibility to, and growth of, liver tumors. To establish guidelines for water safety requires the demonstration of dose-dependent effects of toxicity and experimental determination of maximum “no-adverse-effect levels.” This paper describes the use of growing pigs as a model for human injury resulting from Microcystis toxins in drinking water. Risk assessment calculations using a series of safety factors are carried out, resulting in a guideline level after incorporating an additional safety factor for tumor promotion of approximately 1.0 μg toxins/L. With the Microcystis used for this trial, that concentration corresponds to 5000 cells/mL. © 1994 by John Wiley & Sons, Inc.. 相似文献
73.
Hirofumi CHIBA Surapon PIBOONPOCANUN Hiroaki MITSUZAWA Koji KURONUMA Robert C. MURPHY Dennis R. VOELKER 《Respirology (Carlton, Vic.)》2006,11(Z1):S2-S6
Objectives: The pulmonary surfactant system of the human lung consists of unique lipids and proteins that contribute to the biophysical and innate immune properties of the organ. Surfactant protein A (SP‐A) is an oligomeric protein consisting of 18 protomers with collagen and lectin–like domains that recognizes glycoconjugates, lipids and protein determinants on both host cells and invading microorganisms. The authors examined the interaction of SP‐A with Mycoplasma pneumoniae and the influence of the protein upon the innate immune response to the bacteria. Methodology: The authors quantified SP‐A interaction with bacteria using ELISA, and identified the major surface ligand by thin layer chromatography, HPLC and mass spectrometry. The inflammatory response of human and rat macrophages was measured by quantifying tumour necrosis factor‐α secretion using ELISA, and nitric oxide production. Results: SP‐A bound the bacteria with high affinity and enhanced the inflammatory response of human and rat macrophages to the organism and its membranes. Analysis of the interaction of SP‐A with the bacteria revealed that the major ligand was a phospholipid. The lipid ligand was purified by a combination of thin layer and HPLC, and identified by mass spectrometry. The mass spectrometry demonstrated that the SP‐A reactive lipid consisted of several disaturated molecular species of phosphatidylglycerol (PtdGro). Additional experiments were performed to determine if disaturated PtdGro was capable of interfering with the action of SP‐A as an inhibitor of bacterial lipopolysaccharide‐induced inflammatory mediator production by macrophages. The disaturated PtdGro failed to alter the anti‐inflammatory action of SP‐A but unexpectedly these same studies revealed that unsaturated PtdGro can modify the host response to lipopolysaccharide. Conclusions: These findings reveal that both the lipids and proteins of pulmonary surfactant play a role in regulating the host response to invading microorganisms. 相似文献
74.
75.
76.
77.
78.
John R. Wanamaker Dennis H. Kraus Charles V. Biscotti Isaac Eliachar 《Head & neck》1994,16(6):589-593
Background. Nasopharyngeal carcinoma has a variety of presentations. However, in more than 50% of cases it may present with serous otitis or cervical metastases. Although the metastases usually occur in the neck, the lymphatic network of the parotid may also serve as a site for the metastatic deposits. We present a case in which the initial manifestation of nasopharyngeal carcinoma of the lymphoepithelioma type was a parotid mass. Methods. Case study. Results. A patient who was initially seen with an isolated parotid mass was found to have an undifferentiated carcinoma of the lymphoepithelial type. Further evaluation identified an occult nasopharyngeal carcinoma, and the patient underwent radiotherapy. Conclusions. A diagnosis of a malignant lymphoepithelial lesion of the parotid gland or undifferentiated carcinoma of the lymphoepithelial type mandates a search for an occult primary nasopharyngeal tumor. 相似文献
79.
A. Rojas R. J. Hodgkiss M. R. Stratford M. F. Dennis H. Johns 《British journal of cancer》1993,68(6):1115-1121
Plasma concentrations, after administration of varying doses of nicotinamide, were measured in CBA male mice using a newly-developed high performance liquid chromatography assay. In all dose groups, peak levels were observed within the first 15 min after an i.p. administration of 0.1, 0.2, 0.3 or 0.5 mg g-1 of nicotinamide. There was a clear dose-dependent increase in plasma concentration with increasing dose, with almost a five-fold lower concentration (1.0 vs 4.9 mumol ml-1) achieved with a dose of 0.1 mg g-1 compared with 0.5 mg g-1, respectively. The half-life of nicotinamide increased from 1.4 h to 2.2 h over the dose range (P < 0.01). Comparisons with previous pharmacokinetic data in humans show that clinically-relevant oral doses of 6 and 9 g in humans give plasma levels slightly higher than those achieved at 1 h with doses of 0.1 to 0.2 mg g-1 in mice. Tumour radiosensitisation with carbogen alone, and with carbogen combined with varying doses of nicotinamide (0.05 to 0.5 mg g-1), was investigated using a 10-fraction in 5 days X-ray schedule. Relative to air-breathing mice, a statistically significant increase in sensitisation was observed with both a local tumour control and with an in vivo/in vitro excision assay (P < or = 0.007). With the local control assay, a trend was observed towards lower enhancement ratios (ERs) with decreasing nicotinamide dose (from 1.85 to 1.55); carbogen alone was almost as effective as when combined with 0.1 mg g-1 of nicotinamide. With the excision assay, ERs for carbogen combined with nicotinamide increased with decreased levels of cell survival. At a surviving fraction of 0.02, enhancement ratios of 1.39-1.48 were obtained for carbogen plus 0.1 to 0.3 mg g-1 of nicotinamide. These were lower than those seen with the two higher doses of 0.4 to 0.5 mg g-1 (ERs = 1.63-1.69). 相似文献
80.